Related Experiment Video
Updated: Jan 20, 2026
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Cardiac ScoreCard: A Diagnostic Multivariate Index Assay System for Predicting a Spectrum of Cardiovascular Disease
Michael P McRae1, Biykem Bozkurt2,3, Christie M Ballantyne3
1Department of Bioengineering, Rice University, Houston, TX, USA.
Insights
The Cardiac ScoreCard uses novel biomarkers and patient data to predict heart failure and cardiac wellness, improving cardiovascular disease diagnosis. This system offers better accuracy and seamless integration for clinical decision support.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Machine Learning in Healthcare
Background:
- Clinical decision support systems (CDSSs) show promise for cardiovascular disease (CVD) management but face adoption barriers due to poor interpretability and integration issues.
- Early detection and monitoring of CVD risk factors and biomarkers are crucial for improving patient outcomes and reducing healthcare costs.
Purpose of the Study:
- To introduce the Cardiac ScoreCard, a multivariate index assay system designed to aid in the diagnosis and prognosis of various cardiovascular diseases.
- To develop a CDSS that integrates patient demographics and novel biomarker data for predicting heart failure (HF) and cardiac wellness.
Main Methods:
- Developed the Cardiac ScoreCard using lasso logistic regression models trained on a dataset of 579 patients, incorporating 6 traditional risk factors and 14 biomarker measurements.
- Assessed prediction performance using 5-fold cross-validation and compared results against reference methods.
- Employed a lasso-based feature selection process for biomarker down-selection and provided a framework for integration with point-of-care microdevices.
Main Results:
- The Cardiac ScoreCard models demonstrated improved discrimination for disease versus non-case, achieving an AUC of 0.8403 for cardiac wellness and 0.9412 for HF.
- Models exhibited good calibration, and logistic regression coefficients provided clinical insights, indicating that multimarker panels enhance predictive performance over traditional risk factors alone.
- The system facilitates seamless integration with biomarker measurements from point-of-care medical microdevices.
Conclusions:
- The Cardiac ScoreCard system effectively enhances the prediction of heart failure and cardiac wellness by combining traditional risk factors with a diverse multimarker panel.
- The system's interpretability and seamless integration framework address key limitations of current CDSSs, paving the way for wider adoption in cardiovascular care.
- This approach offers a significant advancement in leveraging biomarker data for improved cardiovascular disease diagnosis and prognosis.
Abstract:
Clinical decision support systems (CDSSs) have the potential to save lives and reduce unnecessary costs through early detection and frequent monitoring of both traditional risk factors and novel biomarkers for cardiovascular disease (CVD). However, the widespread adoption of CDSSs for the identification of heart diseases has been limited, likely due to the poor interpretability of clinically relevant results and the lack of seamless integration between measurements and disease predictions. In this paper we present the Cardiac ScoreCard-a multivariate index assay system with the potential to assist in the diagnosis and prognosis of a spectrum of CVD. The Cardiac ScoreCard system is based on lasso logistic regression techniques which utilize both patient demographics and novel biomarker data for the prediction of heart failure (HF) and cardiac wellness. Lasso logistic regression models were trained on a merged clinical dataset comprising 579 patients with 6 traditional risk factors and 14 biomarker measurements. The prediction performance of the Cardiac ScoreCard was assessed with 5-fold cross-validation and compared with reference methods. The experimental results reveal that the ScoreCard models improved performance in discriminating disease versus non-case (AUC = 0.8403 and 0.9412 for cardiac wellness and HF, respectively), and the models exhibit good calibration. Clinical insights to the prediction of HF and cardiac wellness are provided in the form of logistic regression coefficients which suggest that augmenting the traditional risk factors with a multimarker panel spanning a diverse cardiovascular pathophysiology provides improved performance over reference methods. Additionally, a framework is provided for seamless integration with biomarker measurements from point-of-care medical microdevices, and a lasso-based feature selection process is described for the down-selection of biomarkers in multimarker panels.
Related Concept Videos
09:09In Silico Clinical Trials for Cardiovascular Disease
06:35Basics of Multivariate Analysis in Neuroimaging Data
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
13:51Cross-Modal Multivariate Pattern Analysis
07:25Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease